LPS is a component of Gram-negative bacteria and a potent inducer of innate immune responses via Toll-like receptor 4 (TLR4) signaling, and increased response to LPS is often observed in chronic inflammatory models, including cancer (Naler et al, 2022; Zhu et al, 2023). Here, TLR4 is linked to cancer.